Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of “Hold” from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has received an average recommendation of “Hold” from the nine brokerages that are presently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $11.31.

A number of analysts recently issued reports on the stock. Canaccord Genuity Group raised their target price on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Stifel Nicolaus dropped their target price on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, January 17th. Needham & Company LLC lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 17th. Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Finally, Barclays increased their price objective on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Friday, March 1st.

Definitive Healthcare Stock Performance

Definitive Healthcare stock opened at $7.15 on Tuesday. Definitive Healthcare has a fifty-two week low of $5.53 and a fifty-two week high of $12.45. The company has a market capitalization of $842.20 million, a price-to-earnings ratio of -4.02, a PEG ratio of 6.09 and a beta of 1.39. The stock has a fifty day moving average of $8.04 and a two-hundred day moving average of $8.31. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The firm had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. On average, analysts anticipate that Definitive Healthcare will post 0.11 EPS for the current fiscal year.

Institutional Trading of Definitive Healthcare

A number of institutional investors have recently modified their holdings of DH. Global Retirement Partners LLC increased its holdings in Definitive Healthcare by 86.0% in the 3rd quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock valued at $31,000 after purchasing an additional 1,928 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Definitive Healthcare by 599.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock worth $58,000 after buying an additional 4,959 shares during the period. Norden Group LLC acquired a new stake in shares of Definitive Healthcare in the first quarter valued at about $83,000. Berry Wealth Group LP purchased a new stake in shares of Definitive Healthcare during the 1st quarter valued at about $99,000. Finally, SG Americas Securities LLC acquired a new position in Definitive Healthcare during the 3rd quarter worth approximately $116,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.